Stable cefoperazone medicine prparation

A technology of cefoperazone and pharmaceutical preparations, which is applied in the field of cefoperazone pharmaceutical preparations, can solve problems such as poor stability of cefoperazone sodium, and achieve the effect of stable product quality

Inactive Publication Date: 2007-09-19
GUANGZHOU BAIYUSN TIANXIN PHARMA
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] For the weak point of the poor stability of cefoperazone sodium, the object of the present invention is to provide the compos...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Stable cefoperazone medicine prparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Cefoperazone Acid: Sodium Carbonate

[0036] It can be known from the above table that according to the pH range of 5.5-7.5, the value range of cefoperazone acid and sodium carbonate: 1:0.102-0.082. None of its colors are darker than the yellow No. 4 color, and the dissolution time is not longer than 60S.

Embodiment 2

[0038] Cefoperazone Acid: Sodium Bicarbonate

[0039] It can be seen from the above table that according to the pH range of 5.5-7.5, the value range of cefoperazone acid and sodium bicarbonate: 1:0.20-0.10. None of its colors are deeper than the yellow No. 3 color, and the dissolution time is not more than 80S.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a stable compound preparation of cefoperazone drug, which is comprised by cefoperazone acid and latent solvent, which weight ratio is 1:0.62~0.06. The latent solvent is preferred selected from sodium carbonate and sodium bicarbonate. Related substances of the compound preparation in the invention and labelled content do not change much in influencing factor and accelerated test in 40 DEG C., which accord with the standard of pharmacopoeia, and the product quality is more stable than cefoperazone sodium during period of validity.

Description

technical field [0001] The invention relates to a pharmaceutical preparation of cefoperazone, in particular to a stable cefoperazone powder for injection with synergistic effect for clinical use. technical background [0002] Due to the poor stability of cefoperazone sodium, in order to ensure that the product is qualified within the validity period, it must be stored in a dry and cold place. In the Chinese Pharmacopoeia (2005 edition), the dry product content of cefoperazone sodium preparations should not be less than 88%, the labeled amount should be 95% to 105%, and its related substances should not be greater than 6%. However, the restrictions on content and related substances of similar varieties are more stringent , thus indicating that cefoperazone sodium is unstable. This is the deficiency of all preparations of cefoperazone sodium. [0003] Currently, cefoperazone acid is generally not used clinically due to its water insoluble properties. But through the compari...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/546A61K47/02A61K47/16A61K9/08A61P31/04
Inventor 谭胜连傅红燕林宝儿陈颖唐润珊
Owner GUANGZHOU BAIYUSN TIANXIN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap